Central Nervous System (CNS) therapeutics Market Research Reports
Title | published | price | |
---|---|---|---|
Dementia (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... System) pipeline landscape.
Dementia is the loss of mental functions such as thinking, memory, and reasoning that is severe enough to interfere with a person's daily functioning. Symptoms include memory loss, hallucinations, agitation, p......" | 30-Jun-2021 | $2500 | |
Epilepsy (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... System) pipeline landscape.
Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in the brain which causes seizures. This leads to brief disruptions of the senses and sh......" | 30-Jun-2021 | $2500 | |
Alzheimer's Disease (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... eimer's Disease (Central Nervous System) pipeline landscape.
Alzheimer's disease is a progressive, degenerative condition causing damage to the memory and behavior due to the attack on the neurons. These neurons are responsible for the s......" | 30-Jun-2021 | $2500 | |
Batten Disease (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... (Central Nervous System) pipeline landscape.
Batten disease, a rare genetic disorder, belongs to a group of progressive degenerative neurometabolic disorders known as the neuronal ceroid lipofuscinoses. Symptoms of Batten disease usuall......" | 30-Jun-2021 | $2000 | |
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... nt, 2021, provides an overview of the Chronic Inflammatory Demyelinating Polyneuropathy (Central Nervous System) pipeline landscape.
Chronic inflammatory demyelinating polyneuropathy (CIDP) also called as chronic relapsing polyneuropathy......" | 30-Jun-2021 | $2000 | |
Trigeminal Neuralgia (Tic Douloureux) (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... Neuralgia (Central Nervous System) pipeline landscape.
Trigeminal neuralgia is a chronic pain condition that affects the trigeminal nerve, which carries sensation from face to brain. Symptoms include spontaneous attacks of pain or attac......" | 30-Jun-2021 | $2000 | |
Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... an overview of the Attention Deficit Hyperactivity Disorder (Central Nervous System) pipeline landscape.
Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity and i......" | 30-Jun-2021 | $2000 | |
Spinal Muscular Atrophy (SMA) (Central Nervous System) - Drugs In Development, 2021By Global Markets Direct "...... Atrophy (Central Nervous System) pipeline landscape.
Spinal muscular atrophy (SMA) is a genetic disease that attacks nerve cells, called motor neurons, in the spinal cord. These critically important cells are responsible for supplying e......" | 30-Jun-2021 | $2000 | |
Peripheral Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... rovides comprehensive information on the therapeutics under development for Peripheral Neuropathic Pain, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The repo......" | 30-Apr-2021 | $2000 | |
Peripheral Neuropathy (Sensory Neuropathy) (Central Nervous System) - Drugs in Development, 2021By Global Markets Direct "...... pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Peripheral Neuropathy (Sensory Neuropathy), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA......" | 30-Apr-2021 | $2000 | |
|